PinnyPeptide

Crystagen vs Ovagen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Crystagen

Bioregulators

Khavinson short peptide bioregulator targeting thymus / immune cells.

Peptide B

Ovagen

Bioregulators

Khavinson short peptide bioregulator targeting hepatocytes and liver function.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Crystagen effects

  • Reported improvement in T-cell numbers and function
  • Restoration of age-related immune decline (Russian observational)
  • Support of thymic function in elderly patients
  • Anti-inflammatory effects
  • Recovery support after severe illness

Ovagen effects

  • Reported normalization of elevated liver enzymes
  • Improvement in synthetic liver function markers
  • Support of hepatocyte regeneration
  • Anti-inflammatory effects in chronic liver disease
  • Modulation of hepatic gene expression

Crystagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Theoretical: caution in active autoimmune disease (immune modulation)

Ovagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation

Crystagen dosing ranges

Immune support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Ovagen dosing ranges

Hepatic support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Crystagen guide → Full Ovagen guide →

Crystagen vs Ovagen — common questions

What is the difference between Crystagen and Ovagen?

Crystagen: Khavinson short peptide bioregulator targeting thymus / immune cells. Typical dose 1,000-5,000 mcg. Ovagen: Khavinson short peptide bioregulator targeting hepatocytes and liver function. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Crystagen and Ovagen?

Stacking Crystagen with Ovagen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Crystagen or Ovagen?

Crystagen is typically dosed: Once daily (SubQ) or sublingual for Immune support. Ovagen is typically dosed: Once daily (SubQ) or sublingual for Hepatic support.

Are Crystagen and Ovagen FDA approved?

Crystagen: Not FDA approved. Ovagen: Not FDA approved.

Related peptide comparisons

bronchogen vs crystagencardiogen vs crystagencartalax vs crystagencortagen vs crystagencrystagen vs pancragenbronchogen vs ovagen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free